Pfizer expects results from its study of the Covid-19 drug Paxlovid in high-risk children by the end of the year
The FDA has cleared Merck’s new Covid-19 therapy molnupiravir, the latest antiviral that adults can take at home to avoid severe disease. WSJ’s Daniela Hernandez explains the science behind the new drug. Photo: MerckPfizer Inc. has begun studying its Covid-19 pill in children under 18 years old who are at high risk of developing severe disease.
The study will evaluate whether the five-day treatment Paxlovid, which is in use among people 12 years and older, can also keep children who are newly infected by the coronavirus out of the hospital, Pfizer said Wednesday.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study links even mild Covid-19 to changes in the brainThe study found the brains of those who had Covid-19 had a greater loss of grey matter and abnormalities in the brain tissue compared with those who didn't have Covid-19. Many of those changes were in the area of the brain related to the sense of smell.
Read more »
New Study Links Even Mild COVID-19 to Brain ChangesThe study, published Monday in the journal “Nature,” is believed to be the largest of its kind. It found that the brains of those who had COVID-19 had a greater loss of grey matter and abnormalities in the brain tissue compared with those who didn’t have COVID-19.
Read more »
Requiring masks in K-12 schools cut Covid-19 infections, study showsAs states are rolling back masking requirements for students, a new study shows masks helped cut Covid-19 infections in public K-12 schools that required them in the fall.
Read more »
COVID-19 leads to loss of gray matter in brain, study showsScientists compared brain imaging from more than 400 people who had COVID-19 which nearly 400 people who were not infected.
Read more »
Mild COVID-19 cases still linked to brain damage, study findsResearchers in Britain have discovered that tissue damage in the brain can still occur even in coronavirus infections that have mild symptoms.
Read more »